Press release
11 July 2022
Cellular Goods PLC
('Cellular Goods' or 'the Company')
Launch of minis
Cellular Goods (LSE: CBX), a UK-based wellness company providing premium consumer products formulated with lab-produced cannabinoids, is pleased to announce the launch of mini-size formats for two products, the Rejuvenating Cannabinoid Face Serum and the Calming Cannabinoid After Shaving Moisturiser, in its 'Look Better' (skincare) range.
The new sizes are designed to be compact and convenient for travel as well as provide an entry-level price point to encourage more consumers to trial the products or buy them as gifts, broadening the brand's footprint.
The 30ml after-shaving moisturiser has a retail price of £32 and the 15ml serum retails at £54. Both are available for purchase on the Amazon Marketplace and the Company's ecommerce website, www.cellular-goods.com, from today.
As with their full-size equivalents, the minis have been through an extensive testing process and are fully validated for marketing and labelling as suitable for sensitive skin, dermatologically tested and dermatologist approved. The entire Look Better range is formulated with cannabigerol (CBG), which the Company's white paper indicated has both antioxidant and anti-inflammatory effects, making it a skincare ingredient with powerful anti-aging potential.
The after-shaving moisturiser also contains the Cellular Goods' patent-pending skin-brightening complex, which can improve skin-tone evenness associated with various factors, including melasma and hyperpigmentation.
The Rejuvenating Cannabinoid Face Serum and the Calming Cannabinoid After Shaving Moisturiser use lab-made CBG, which does not require the cultivation of the cannabis sativa plant and contains 0% THC, the psychoactive component of cannabis sativa.
For further information please contact:
| Cellular Goods | |
| Anna Chokina Chief Executive Neil Thapar Investor Relations | via Tancredi +44 207 887 7633
+44 787 645 5323 |
| Tennyson Securities | |
| Corporate Broker Peter Krens |
+44 207 186 9030 |
| Novum Securities |
|
| Corporate Broker Colin Rowbury Jon Belliss |
+44 207 399 9427 |
| Tancredi Intelligent Communication | |
| Media Relations Helen Humphrey Gabriela Amaya Garcia Charlie Hobbs |
+44 744 922 6720 +44 791 503 5294 +44 789 755 7112 |
About Cellular Goods PLC:
Cellular Goods is a UK-based wellness company that provides premium products based on lab-made cannabinoids. It was established in August 2018 to develop efficacy-led and research-backed cannabinoid-powered wellness products. The initial focus is on three product verticals: Function Better, Feel Better and Look Better. These three verticals encompass Cellular Goods' premium CBG skincare and CBD ingestible and topical athletic recovery products, with the first products launched in December 2021 initially through the Company's website. The Company's shares are listed on the main market of the London Stock Exchange. www.cellular-goods.com
Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
